GGrantIndex
← Leaderboards

James P. Zacny

University Of Chicago

$6,008,136
Attributed
$6,008,136
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $663.4K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$6,008,136 · 6

By mechanism

R01$4,598,828 · 4
R37$980,308 · 1
R21$429,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchPainPsychopharmacologyAnalgesicsPsychomotor FunctionMorphineHuman SubjectBehavioral /Social Science Research TagDrug InteractionsLaboratoriesOpioidPharmaceutical PreparationsDoseRecording Of Previous EventsEthanolReinforcerOpioid AbuseEuphoriaFaceMethodologyOralBaseDrug UsageMedical

Grant awards (21)

Methylnaltrexone: Pharmacological Probe of Morphine Effects$195,000
R21 · FY2012 · DA · contact PI
Methylnaltrexone: Pharmacological Probe of Morphine Effects$234,000
R21 · FY2011 · DA · contact PI
Abuse-Related Effects of Opioids and Adjuvant Drug Used by Chronic Pain Patients$325,639
R01 · FY2010 · DA · contact PI
Abuse-Related Effects of Opioids and Adjuvant Drug Used by Chronic Pain Patients$329,892
R01 · FY2009 · DA · contact PI
Behavioral Effects of Opioids in Volunteers$329,752
R01 · FY2009 · DA · contact PI
Behavioral Effects of Opioids in Volunteers$328,410
R01 · FY2008 · DA · contact PI
Abuse-Related Effects of Opioids and Adjuvant Drug Used by Chronic Pain Patients$322,094
R01 · FY2008 · DA · contact PI
Abuse-Related Effects of Opioids and Adjuvant Drug Used by Chronic Pain Patients$344,077
R01 · FY2007 · DA · contact PI
Behavioral Effects of Opioids in Volunteers$319,286
R01 · FY2007 · DA · contact PI
Behavioral Effects of Opioids in Volunteers$326,595
R01 · FY2006 · DA · contact PI
Behavioral Effects of Opioids in Volunteers$318,738
R01 · FY2005 · DA
CHARACTERIZING PSYCHOACTIVE EFFECTS OF INHALANTS$309,663
R01 · FY2004 · DA
CHARACTERIZING PSYCHOACTIVE EFFECTS OF INHALANTS$276,852
R01 · FY2003 · DA
BEHAVIORAL EFFECTS OF OPIOIDS IN VOLUNTEERS$255,010
R37 · FY2003 · DA
CHARACTERIZING PSYCHOACTIVE EFFECTS OF INHALANTS$278,533
R01 · FY2002 · DA
BEHAVIORAL EFFECTS OF OPIOIDS IN VOLUNTEERS$251,859
R37 · FY2002 · DA
CHARACTERIZING PSYCHOACTIVE EFFECTS OF INHALANTS$295,567
R01 · FY2001 · DA
BEHAVIORAL EFFECTS OF OPIOIDS IN VOLUNTEERS$243,960
R37 · FY2001 · DA
CHARACTERIZING PSYCHOACTIVE EFFECTS OF INHALANTS$274,365
R01 · FY2000 · DA
BEHAVIORAL EFFECTS OF OPIOIDS IN VOLUNTEERS$229,479
R37 · FY2000 · DA
GENDER &OPIOID EFFECTS, INCLUDING ANALGESIA$219,365
R01 · FY2000 · DA